Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays
Programmed death-ligand 1 (PD-L1) expression on tumor cells (TC) or tumor-infiltrating immune cells (IC) correlated in several studies with PD-L1/programmed death-1 (PD-1) checkpoint inhibitor efficacy. Since June 2018, a positive PD-L1 status is required for atezolizumab or pembrolizumab treatment...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2 July 2019
|
| In: |
Virchows Archiv
Year: 2019, Volume: 475, Issue: 5, Pages: 599-608 |
| ISSN: | 1432-2307 |
| DOI: | 10.1007/s00428-019-02610-z |
| Online Access: | Verlag, Volltext: https://doi.org/10.1007/s00428-019-02610-z |
| Author Notes: | Kristina Schwamborn, Johannes U. Ammann, Ruth Knüchel, Arndt Hartmann, Gustavo Baretton, Felix Lasitschka, Peter Schirmacher, Till Braunschweig, Robert Tauber, Franziska Erlmeier, Stefanie Hieke-Schulz, Wilko Weichert |
Search Result 1
Search Result 2
Search Result 3